Never lived within distance | Ever lived within distance | Average annual emission index | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | |||||||||||||||
Cases | Controls | OR (95%CI)a | Cases | Controls | OR (95%CI)a | Cases | Controls | OR (95%CI)a | Cases | Controls | OR (95%CI)a | Cases | Controls | OR (95%CI)a | Cases | Controls | OR (95%CI)a | |
5 km | ||||||||||||||||||
All NHL | 595 | 459 | 1.0 | 374 | 290 | 1.0 (0.8-1.2) | 97 | 73 | 1.0 (0.7-1.4) | 102 | 72 | 1.1 (0.7-1.5) | 85 | 73 | 0.9 (0.6-1.3) | 90 | 72 | 1.0 (0.7-1.4) |
DLBCL | 182 | 459 | 1.0 | 122 | 290 | 1.0 (0.7-1.3) | 30 | 73 | 1.0 (0.6-1.6) | 28 | 72 | 0.9 (0.5-1.5) | 32 | 73 | 1.0 (0.6-1.6) | 32 | 72 | 1.0 (0.6-1.7) |
Follicular | 141 | 459 | 1.0 | 86 | 290 | 1.0 (0.7-1.4) | 22 | 73 | 0.9 (0.5-1.6) | 26 | 72 | 1.1 (0.7-1.9) | 18 | 73 | 0.8 (0.4-1.5) | 20 | 72 | 1.0 (0.5-1.7) |
CLL/SLL | 66 | 459 | 1.0 | 36 | 290 | 0.8 (0.5-1.3) | 9 | 73 | 0.9 (0.4-2.0) | 8 | 72 | 0.7 (0.3-1.6) | 9 | 73 | 0.8 (0.3-1.7) | 10 | 72 | 0.9 (0.4-1.9) |
Marginal zone | 57 | 459 | 1.0 | 25 | 290 | 1.1 (0.6-1.8) | 5 | 73 | 0.5 (0.2-1.5) | 10 | 72 | 1.5 (0.7-3.3) | 2 | 73 | 0.5 (0.1-2.2) | 8 | 72 | 2.6 (1.0-6.8) |
Other subtypes | 78 | 459 | 1.0 | 50 | 290 | 0.8 (0.5-1.3) | 15 | 73 | 1.2 (0.6-2.3) | 12 | 72 | 0.8 (0.4-1.6) | 13 | 73 | 0.7 (0.3-1.5) | 10 | 72 | 0.5 (0.2-1.2) |
NOS lymphoma | 71 | 459 | 1.0 | 55 | 290 | 1.4 (0.9-2.2) | 16 | 73 | 1.4 (0.8-2.7) | 18 | 72 | 1.8 (1.0-3.3) | 11 | 73 | 1.1 (0.5-2.4) | 10 | 72 | 1.1 (0.5-2.5) |
3 km | ||||||||||||||||||
All NHL | 754 | 579 | 1.0 | 215 | 170 | 1.0 (0.8-1.3) | 67 | 43 | 1.2 (0.8-1.8) | 39 | 42 | 0.7 (0.5-1.2) | 52 | 43 | 0.9 (0.6-1.4) | 57 | 42 | 1.1 (0.7-1.7) |
DLBCL | 235 | 579 | 1.0 | 69 | 170 | 0.9 (0.6-1.3) | 22 | 43 | 1.2 (0.7-2.1) | 11 | 42 | 0.6 (0.3-1.2) | 14 | 43 | 0.7 (0.4-1.3) | 22 | 42 | 1.2 (0.7-2.1) |
Follicular | 178 | 579 | 1.0 | 49 | 170 | 1.0 (0.6-1.4) | 18 | 43 | 1.3 (0.7-2.5) | 6 | 42 | 0.5 (0.2-1.1) | 11 | 43 | 0.8 (0.4-1.7) | 14 | 42 | 1.1 (0.6-2.2) |
CLL/SLL | 81 | 579 | 1.0 | 21 | 170 | 0.9 (0.5-1.6) | 3 | 43 | 0.6 (0.2-1.9) | 4 | 42 | 0.7 (0.2-2.0) | 9 | 43 | 1.7 (0.7-3.7) | 5 | 42 | 0.8 (0.3-2.3) |
Marginal zone | 66 | 579 | 1.0 | 16 | 170 | 1.3 (0.7-2.4) | 3 | 43 | 0.7 (0.2-2.3) | 4 | 42 | 1.3 (0.4-3.9) | 3 | 43 | 1.1 (0.3-4.0) | 6 | 42 | 3.0 (1.1-8.3) |
Other subtypes | 101 | 579 | 1.0 | 27 | 170 | 0.8 (0.5-1.3) | 8 | 43 | 1.0 (0.5-2.3) | 8 | 42 | 1.0 (0.4-2.2) | 6 | 43 | 0.6 (0.3-1.6) | 5 | 42 | 0.6 (0.3-2.5) |
NOS lymphoma | 93 | 579 | 1.0 | 33 | 170 | 1.5 (0.9-2.3) | 13 | 43 | 2.1 (1.1-4.2) | 6 | 42 | 1.1 (0.4-2.7) | 9 | 43 | 1.5 (0.6-3.2) | 5 | 42 | 0.9 (0.3-2.5) |